✦ LIBER ✦

Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk

✍ Scribed by H. Dean Hosgood III; Dalsu Baris; Yawei Zhang; Sonja I. Berndt; Idan Menashe; Lindsay M. Morton; Kyoung-Mu Lee; Meredith Yeager; Shelia H. Zahm; Stephen Chanock; Tongzhang Zheng; Qing Lan

Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 321 KB
Volume: 33
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2009.03.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Variation in innate immunity genes and r

Variation in innate immunity genes and risk of multiple myeloma

✍ Mark P. Purdue; Qing Lan; Idan Menashe; Tongzhang Zheng; Yawei Zhang; Meredith Y 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Multiple myeloma (MM) is a B-cell lymphoid malignancy suspected to be associated with immunologic factors. Given recent findings associating single-nucleotide polymorphisms (SNPs) in innate immunity genes with non-Hodgkin lymphoma, we conducted an investigation of innate immune gene variants using s

Artificial Zinc(II) Complexes Regulate C

Artificial Zinc(II) Complexes Regulate Cell Cycle and Apoptosis-Related Genes in Tumor Cell Lines

✍ Jian Gao ; Ya-Guang Liu; Yaqing Zhou; Linda M. Boxer; F. Ross Woolley; Ralph A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 771 KB

## Abstract Various proteins involved in transcriptional regulation possess highly selective DNA‐binding domains, known as zinc fingers. However, little is known about small‐molecule zinc(II) complexes in the regulation of gene expression and programmed cell death. A new family of zinc(II) complexe

Genetic variations in benzene metabolism

Genetic variations in benzene metabolism and susceptibility to multiple myeloma

✍ Lisa F. Lincz; Fiona E. Scorgie; Richard Robertson; Arno Enno 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 115 KB

We have previously shown that deficiency in the biotransformation enzyme glutathione-S-transferase theta (GSTT1) is a risk factor for multiple myeloma (MM). The present case-control study of 102 MM patients and 205 controls revealed a significant trend in increasing risk of MM with inheritance of mu

Genetic variations in cell-cycle pathway

Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions

✍ Yuanqing Ye; Scott M. Lippman; J. Jack Lee; Meng Chen; Marsha L. Frazier; Margar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Common variants in genes that mediate im

Common variants in genes that mediate immunity and risk of multiple myeloma

✍ Elizabeth E. Brown; Qing Lan; Tongzhang Zheng; Yawei Zhang; Sophia S. Wang; Shel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 179 KB 👁 2 views

## Abstract Multiple myeloma (MM) is a B‐cell malignancy characterized by aberrant immune function. Using genomic DNA extracted from 127 MM cases aged 21–84 years and 545 population‐based controls, we examined the risk of MM associated with 82 common variants in 45 genes that mediate immunity among

Genetic variation in MicroRNA genes and

Genetic variation in MicroRNA genes and risk of oral premalignant lesions

✍ Jessica Clague; Scott M. Lippman; Hushan Yang; Michelle A.T. Hildebrandt; Yuanqi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract MicroRNAs (miRNAs) have been reported to play a key role in oncogenesis and, recently, studies have examined the role miRNAs might play in the risk of premalignant lesions. To our knowledge, no study has investigated the association between miRNA polymorphisms and risk of oral premalign